SIRT3 and cardiac hypertrophy: SIRT3 overexpression blocks hypertrophy both in vitro and in vivo, whereas SIRT3−/− mice exhibit enhanced susceptibility to hypertrophy (Sundaresan et al., 2009), likely indirectly protecting against cardiac hypertrophy by specifically control of ROS levels.